Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Complement System01:27

Complement System

10.8K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.8K
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

221
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
221

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

<i>Moss-derived</i> recombinant Factor H, CPV-104, effectively antagonizes alternative pathway C3/C5 convertases stabilization by NeFs from patients with primary C3 glomerulopathy.

Frontiers in immunology·2026
Same author

C3 Glomerulopathy With Occult Gammopathy Treated With Low-Dose, Fixed Duration Venetoclax.

Kidney international reports·2026
Same author

Intraepidermal Merkel Cell Carcinoma in Association With Squamous Cell Carcinoma In Situ and Adjacent Invasive Merkel Cell Carcinoma.

The American Journal of dermatopathology·2026
Same author

Hypoimmunogenic iPSC-derived hepatic organoids featuring a functional vascular network.

Scientific reports·2026
Same author

Complement-Mediated Postpartum Atypical Hemolytic Uremic Syndrome With Collapsing Focal Segmental Glomerulosclerosis Associated With a Novel CFHR5 Copy Number Variant.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Anti-nephrin antibodies are not enriched in patients with primary and posttransplant recurrent podocytopathies.

The Journal of clinical investigation·2026

相关实验视频

Updated: May 5, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.6K

向C3d的H因子在疾病模型中抑制了组织补充,并减少了淋巴细胞损伤,而不影响循环补充.

Fei Liu1, Sarah T Ryan1, Kelly C Fahnoe1

  • 1Q32 Bio, Waltham, MA 02451, USA.

Molecular therapy : the journal of the American Society of Gene Therapy
|February 21, 2024
PubMed
概括

这项研究引入了向的融合蛋白,可以局部抑制补充,减少皮肤和脏的疾病活性,而无需系统性免疫抑制. 这种方法为补充介导疾病提供了更安全,更有效的治疗方法.

关键词:
在C3d中,它是C3d.补充补充补充补充补充补充补充.这就是H因子H因子.淋巴细胞疾病是什么?皮肤疾病 皮肤疾病组织向的组织向.

更多相关视频

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

6.0K

相关实验视频

Last Updated: May 5, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.6K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

6.0K

科学领域:

  • 免疫学 免疫学 免疫学
  • 生物技术是生物技术.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 系统补充抑制剂由于大量循环补充剂,因此面临有效性和感染风险的挑战.
  • 针对当地补充的目标提供了一个潜在的解决方案,以克服这些局限性.

研究的目的:

  • 开发和评估用于局部补体抑制的新型抗体融合蛋白.
  • 评估针对组织结合的补充成分的疗效和安全性.

主要方法:

  • 工程抗体融合蛋白结合了H因子 (fH1-5) 和抗C3d单克隆抗体 (C3d-mAb-2fH).
  • 在人类皮肤和灵长类动物损伤模型中,验证了蛋白质与沉积补充剂的结合.
  • 评估了皮肤损伤和膜性脏病的动物模型中的组织补充抑制和疾病修饰.

主要成果:

  • 融合蛋白被证明与患病皮肤中沉积的C3d结合,并在体内局部地与活化补充物结合.
  • 剂量>1 mg/kg在没有全身阻塞的动物模型中实现了>75%的组织补充抑制.
  • 在大鼠模型中,淋巴细胞特异性抑制降低了蛋白尿,并保留了脏结构.

结论:

  • 用C3d-mAb-2fH融合蛋白向本地组织补充剂提供了持久和有效的阻塞.
  • 这种局部化方法避免了系统性抑制,这表明它对补充介导疾病具有广泛的适用性.
  • 该策略提供了一个有希望的治疗途径,降低了感染风险.